Aquestive Therapeutics, Inc. Annual Costs and Expenses in USD from 2019 to 2023

Taxonomy & unit
us-gaap: USD
Description
Total costs of sales and operating expenses for the period.
Summary
Aquestive Therapeutics, Inc. quarterly/annual Costs and Expenses history and growth rate from 2019 to 2023.
  • Aquestive Therapeutics, Inc. Costs and Expenses for the quarter ending September 30, 2024 was $21.8M, a 42% increase year-over-year.
  • Aquestive Therapeutics, Inc. Costs and Expenses for the twelve months ending September 30, 2024 was $80M, a 14.4% increase year-over-year.
  • Aquestive Therapeutics, Inc. annual Costs and Expenses for 2023 was $65.7M, a 26.8% decline from 2022.
  • Aquestive Therapeutics, Inc. annual Costs and Expenses for 2022 was $89.7M.
  • Aquestive Therapeutics, Inc. annual Costs and Expenses for 2020 was $88.7M, a 15.7% decline from 2019.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Annual (USD)
Costs and Expenses, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $65.7M -$24.1M -26.8% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-05
2022 $89.7M Jan 1, 2022 Dec 31, 2022 10-K 2024-03-05
2020 $88.7M -$16.5M -15.7% Jan 1, 2020 Dec 31, 2020 10-K 2021-03-09
2019 $105M Jan 1, 2019 Dec 31, 2019 10-K 2021-03-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.